本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Sutro Biopharma Inc

16.33
-0.5850-3.46%
成交量:118.00萬
成交額:1,837.67萬
市值:2.70億
市盈率:-0.94
高:16.82
開:16.82
低:15.43
收:16.91
52周最高:43.85
52周最低:7.15
股本:1,656.72萬
流通股本:1,076.62萬
量比:4.37
換手率:10.96%
股息:- -
股息率:- -
每股收益(TTM):-17.3700
每股收益(LYR):-22.4900
淨資產收益率:-1810.01%
總資產收益率:-36.08%
市淨率:-2.62
市盈率(LYR):-0.73

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/12

重要事件披露

Form 8-K - Current report
2026/07/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/08

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/15

重要事件披露

Form 8-K - Current report
2026/05/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/21

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/21

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/31

SEC問詢函

Form CORRESP - Correspondence
2026/03/23

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/23

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/23

重要事件披露

Form 8-K - Current report
2026/02/10

重要事件披露

Form 8-K - Current report
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities